TERBINAFINE HYDROCHLORIDE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for terbinafine hydrochloride and what is the scope of patent protection?

Terbinafine hydrochloride is the generic ingredient in three branded drugs marketed by Karo Hlthcare, Novartis, Taro, Aurobindo Pharma, Breckenridge Pharm, Chartwell, Cipla, Dr Reddys Labs Inc, Emed Medcl, Gedeon Richter Usa, Glenmark Pharms Ltd, Heritage Pharma Avet, Invagen Pharms, Mylan, Natco Pharma, Orbion Pharms, Roxane, and Wockhardt, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-five drug master file entries for terbinafine hydrochloride. Forty-five suppliers are listed for this compound. There are four tentative approvals for this compound.

Summary for TERBINAFINE HYDROCHLORIDE

US Patents:	0
Tradenames:	3
Applicants:	18
NDAs:	22
Drug Master File Entries:	25
Finished Product Suppliers / Packagers:	45
Raw Ingredient (Bulk) Api Vendors:	115
Clinical Trials:	45
Patent Applications:	2,563
What excipients (inactive ingredients) are in TERBINAFINE HYDROCHLORIDE?	TERBINAFINE HYDROCHLORIDE excipients list
DailyMed Link:	TERBINAFINE HYDROCHLORIDE at DailyMed

Recent Clinical Trials for TERBINAFINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Dhaka Medical College	Phase 2/Phase 3
Moberg Pharma AB	Phase 3
IQVIA Biotech	Phase 3

See all TERBINAFINE HYDROCHLORIDE clinical trials

Generic filers with tentative approvals for TERBINAFINE HYDROCHLORIDE

Applicant	Application No.	Strength	Dosage Form
⤷ Sign Up	⤷ Sign Up	EQ 250MG BASE	TABLET; ORAL
⤷ Sign Up	⤷ Sign Up	EQ 250MG BASE	TABLET;ORAL
⤷ Sign Up	⤷ Sign Up	EQ 250MG BASE	TABLET;ORAL

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Pharmacology for TERBINAFINE HYDROCHLORIDE

Drug Class	Allylamine Antifungal

Anatomical Therapeutic Chemical (ATC) Classes for TERBINAFINE HYDROCHLORIDE

D01AE	Other antifungals for topical use
D01A	ANTIFUNGALS FOR TOPICAL USE
D01	ANTIFUNGALS FOR DERMATOLOGICAL USE
D	Dermatologicals

D01BA	Antifungals for systemic use
D01B	ANTIFUNGALS FOR SYSTEMIC USE
D01	ANTIFUNGALS FOR DERMATOLOGICAL USE
D	Dermatologicals

US Patents and Regulatory Information for TERBINAFINE HYDROCHLORIDE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Wockhardt	TERBINAFINE HYDROCHLORIDE	terbinafine hydrochloride	TABLET;ORAL	078229-001	Jul 2, 2007		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Cipla	TERBINAFINE HYDROCHLORIDE	terbinafine hydrochloride	TABLET;ORAL	077137-001	Jul 2, 2007		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Dr Reddys Labs Inc	TERBINAFINE HYDROCHLORIDE	terbinafine hydrochloride	TABLET;ORAL	076390-001	Jul 2, 2007	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Karo Hlthcare	LAMISIL AT	terbinafine hydrochloride	SOLUTION;TOPICAL	021124-001	Mar 17, 2000		OTC	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for TERBINAFINE HYDROCHLORIDE

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Karo Hlthcare	LAMISIL AT	terbinafine hydrochloride	SPRAY;TOPICAL	021124-002	Mar 17, 2000	⤷ Sign Up	⤷ Sign Up
Karo Hlthcare	LAMISIL	terbinafine hydrochloride	SOLUTION;TOPICAL	020749-001	Oct 17, 1997	⤷ Sign Up	⤷ Sign Up
Karo Hlthcare	LAMISIL AT	terbinafine hydrochloride	SOLUTION;TOPICAL	021124-001	Mar 17, 2000	⤷ Sign Up	⤷ Sign Up
Karo Hlthcare	LAMISIL AT	terbinafine hydrochloride	SPRAY;TOPICAL	021124-002	Mar 17, 2000	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.